tiprankstipranks
Trending News
More News >
Revolution Medicines (RVMD)
NASDAQ:RVMD
US Market

Revolution Medicines (RVMD) Income Statement

Compare
548 Followers

Revolution Medicines Income Statement

Last quarter (Q3 2025), Revolution Medicines's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Revolution Medicines's net income was $-305.21M. See Revolution Medicines’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 11.58M$ 35.38M$ 29.39M$ 42.98M
Gross Profit
$ -592.23M$ -399.66M$ -217.69M$ -157.56M$ -89.27M
Operating Expenses
$ 97.30M$ 87.52M$ 40.59M$ 30.45M$ 21.43M
Depreciation and Amortization
$ 11.82M$ 5.01M$ 9.66M$ 7.33M$ 6.54M
EBITDA
$ -589.02M$ -456.68M$ -248.62M$ -179.75M$ -101.91M
Operating Income
$ -689.52M$ -487.19M$ -258.28M$ -188.01M$ -110.70M
Other Income/Expenses
$ 88.68M$ 47.29M$ 9.15M$ 917.00K$ 2.17M
Pretax Income
$ -600.85M$ -439.89M$ -249.13M$ -187.09M$ -108.53M
Net Income
$ -600.09M$ -436.37M$ -248.71M$ -187.09M$ -108.16M
Per Share Metrics
Basic EPS
$ -3.58$ -3.86$ -3.08$ -2.47$ -1.62
Diluted EPS
$ -3.58$ -3.86$ -3.08$ -2.47$ -1.62
Weighted Average Shares Outstanding
167.74M 113.15M 80.63M 72.81M 66.60M
Weighted Average Shares Outstanding (Diluted)
167.74M 113.15M 80.63M 72.81M 66.60M
Currency in USD

Revolution Medicines Earnings and Revenue History